$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Controlled onset and sustained release dosage forms and the preparation thereof 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/22
  • A61K-009/24
  • A61K-009/30
출원번호 US-0358732 (1999-07-21)
발명자 / 주소
  • Harinderpal Chhabra
  • Shyamal K. Sarkar
대리인 / 주소
    Kitt Sinden
인용정보 피인용 횟수 : 131  인용 특허 : 1

초록

A pharmaceutical composition for controlled onset and sustained release of an active ingredient, said composition comprising:(i) a core comprising:(a) an active ingredient;(b) a hydrophilic carrier;(c) a hydrodynamic diffusion enhancer; and optionally(d) conventional pharmaceutically acceptable exci

대표청구항

1. A pharmaceutical composition for controlled onset and sustained release of an active ingredient, said composition comprising:(i) a core comprising: (a) an active ingredient; (b) a hydrophilic carrier; (c) a hydrodynamic diffusion enhancer; and optionally (d) conventional pharmaceutically acceptab

이 특허에 인용된 특허 (1)

  1. Bengtsson Inga Siv (Goteborg SEX) Lovgren Kurt Ingmar (Molnlycke SEX), Pharmaceutical formulation of omeprazole.

이 특허를 인용한 특허 (131)

  1. Kumar, Vijai; Dixon, David; Tewari, Divya; Wadgaonkar, Dilip B., Abuse deterrent compositions and methods of making same.
  2. Kumar, Vijai; Dixon, David; Tewari, Divya; Wadgaonkar, Dilip B., Abuse deterrent compositions and methods of making same.
  3. Dharmadhikari, Nitin Bhalachandra; Zala, Yashoraj Rupsinh; Shanghvi, Dilip, Abuse deterrent immediate release coated reservoir solid dosage form.
  4. Dharmadhikari, Nitin Bhalachandra; Zala, Yashoraj Rupsinh; Shanghvi, Dilip, Abuse deterrent immediate release coated reservoir solid dosage form.
  5. Habib, Walid A.; Hamed, Ehab; Vega Zepeda, Manuel A., Abuse resistant drug formulation.
  6. Habib, Walid A.; Hamed, Ehab; Vega Zepeda, Manuel A., Abuse resistant drug formulation.
  7. Habib, Walid A.; Hamed, Ehab; Vega Zepeda, Manuel A., Abuse resistant drug formulation.
  8. Habib, Walid; Hamed, Ehab; Moe, Derek; Kraling, Carrie; Hillman, Lisa, Abuse resistant drug formulation.
  9. Pauls, Heinz W.; Ramnauth, Jailall; Sampson, Peter; Toro, Andras, Acrylamide derivatives as Fab I inhibitors.
  10. Pauls, Heinz W.; Ramnauth, Jailall; Sampson, Peter; Toro, Andras, Acrylamide derivatives as Fab I inhibitors.
  11. Hamed, Ehab, Alcohol-resistant metoprolol-containing extended-release oral dosage forms.
  12. Hagen,Timothy A.; Lo,Julian B.; Thombre,Avinash G.; Herbig,Scott M.; Appel,Leah Elizabeth; Crew,Marshall David; Friesen,Dwayne Thomas; Lyon,David Keith; McCray,Scott Baldwin; West,James Blair, Azithromycin dosage forms with reduced side effects.
  13. Baichwal, Anand R.; Woodcock, Paul; Labudzinski, Steve, Chronotherapeutic dosage forms.
  14. Baichwal, Anand R.; Woodcook, Paul; Higgins, Raymond; Cobb, Jaclyn, Chronotherapeutic dosage forms and methods of treatment using chronotherapy.
  15. Mehta, Ketan; Tu, Yu-Hsing, Clonidine formulation.
  16. Gold, Thomas B.; Woodall, Patrick Brian, Coated tablet with zero-order or near zero-order release kinetics.
  17. Devarakonda, Krishna R.; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia.
  18. Devarakonda, Krishna; Guiliani, Michael J; Gupta, Vishal K; Heasley, Ralph A; Shelby, Susan, Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia.
  19. Cowley, Michael A.; McKinney, Anthony A.; Tollefson, Gary, Compositions and methods for increasing insulin sensitivity.
  20. Cowley, Michael A.; McKinney, Anthony A.; Tollefson, Gary, Compositions and methods for increasing insulin sensitivity.
  21. Balwani, Gul; Sacks, Harry J.; Roecklein, Bryan A.; Johns, Benjamin, Compositions comprising carisoprodol and methods of use thereof.
  22. Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum, Compositions comprising multiple bioactive agents, and methods of using the same.
  23. Weber, Eckard; Cowley, Michael Alexander, Compositions for affecting weight loss.
  24. Kumar, Vijai; Dixon, David; Tewari, Divya; Wadgaonkar, Dilip B., Compositions for deterring abuse of opioid containing dosage forms.
  25. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  26. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  27. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  28. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  29. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  30. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  31. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  32. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  33. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  34. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  35. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  36. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  37. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  38. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  39. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  40. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  41. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  42. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  43. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  44. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  45. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  46. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  47. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Controlled release hydrocodone formulations.
  48. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  49. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  50. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  51. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  52. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  53. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  54. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  55. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  56. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  57. Zerbe, Horst G.; Paiement, Nadine, Controlled-release pharmaceutical tablets.
  58. Baichwal, Anand R.; Woodcock, Paul; Higgins, Raymond; Cobb, Jaclyn, Delayed release dosage forms.
  59. Schaeffler, Achim, Delayed-release glucocorticoid treatment of rheumatoid disease.
  60. Schaeffler, Achim, Delayed-release glucocorticoid treatment of rheumatoid disease.
  61. Cao, Linqiu; Langridge, John Richard; Van Gessel, Alexander Wilhelmus, Extended release excipient and its use.
  62. Horacek, Henry Joseph; He, Min Michael; Khayrallah, Moise A., Extended release formulation and method of treating adrenergic dysregulation.
  63. Gower, Brad L.; Castaneda, Carlos H.; Park, Jae Han; Herman, Clifford J., Extended release, abuse deterrent pharmaceutical compositions.
  64. Thompson, Edwin R.; Thompson, Eric R.; Myslinski, Nicholas R.; Kemeny, Steven F., Extruded extended release abuse deterrent pill.
  65. Thompson, Edwin R.; Thompson, Eric R.; Myslinski, Nicholas R.; Kemeny, Steven F., Extruded extended release abuse deterrent pill.
  66. Thompson, Edwin R.; Thompson, Eric R.; Myslinski, Nicholas R.; Kemeny, Steven F., Extruded immediate release abuse deterrent pill.
  67. Ray, Roderick J.; Appel, Leah E.; Newbold, David D.; Friesen, Dwayne T.; McCray, Scott B.; Lyon, David K.; West, James B.; Crew, Marshall D.; Shockey, Joshua R., Extrusion process for forming chemically stable drug multiparticulates.
  68. Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.; Dewolf, Jr., Walter E.; Jakas, Dalia R., FAB I inhibitors.
  69. Burgess, Walter J.; Jakas, Dalia R.; Huffman, William F.; Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N., Fab I inhibitors.
  70. Burgess, Walter J.; Jakas, Dalia R.; Huffman, William F.; Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N., Fab I inhibitors.
  71. Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.; Dewolf, Jr., Walter E.; Jakas, Dalia R., Fab I inhibitors.
  72. Devarakonda, Krishna R.; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Gastric retentive extended release pharmaceutical compositions.
  73. Devarakonda, Krishna; Guiliani, Michael J; Gupta, Vishal K; Heasley, Ralph A; Shelby, Susan, Gastric retentive extended release pharmaceutical compositions.
  74. Han, Chien-Hsuan; Hou, Sui Yuen Eddie; Reid, Monica L., Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic.
  75. Han, Chien-Hsuan; Hou, Sui Yuen Eddie; Reid, Monica L., Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic.
  76. Han, Chien-Hsuan; Hou, Sui Yuen Eddie; Reid, Monica L., Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic.
  77. Han, Chien-Hsuan; Hou, Sui Yuen Eddie; Reid, Monica L., Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic.
  78. Jacobs, Irwin; Gee, Stephen; Brady, Paul, Gelling agent-based dosage form.
  79. Berman, Judd M.; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall; Manning, David Douglas; Surman, Matthew D.; Xie, Dejian; Decornez, Helene Y., Heterocyclic compounds, methods of making them and their use in therapy.
  80. Thompson, Edwin R.; Thompson, Eric R.; Myslinski, Nicholas R.; Kemeny, Steven F.; Hart, Matthew N., Immediate release abuse deterrent liquid fill dosage form.
  81. Haswani, Dinesh K.; Moe, Derek V.; O'Neill, Victoria A.; Vega Zepeda, Manuel A., Immediate release abuse-deterrent granulated dosage forms.
  82. Haswani, Dinesh K.; Moe, Derek V.; O'Neill, Victoria A.; Vega Zepeda, Manuel A., Immediate release abuse-deterrent granulated dosage forms.
  83. McKinney, Anthony; Tollefson, Gary; Weber, Eckard; Soltero, Rick, Layered pharmaceutical formulations.
  84. McKinney, Anthony; Tollefson, Gary; Weber, Eckard; Soltero, Rick, Layered pharmaceutical formulations.
  85. Lickrish, David; Zhang, Feng, Method of treatment of attention deficit hyperactivity disorder.
  86. Leech, Ronald L.; Hall Yung, Rachelle L.; Brzeczko, Albert W., Methods and compositions for deterring abuse.
  87. Leech, Ronald L.; Hall Yung, Rachelle L.; Brzeczko, Albert W., Methods and compositions for deterring abuse.
  88. Brzeczko, Albert W.; Hollenbeck, R. Gary, Methods and compositions for self-regulated release of active pharmaceutical ingredient.
  89. Brzeczko, Albert W.; Hollenbeck, R. Gary, Methods and compositions for self-regulated release of active pharmaceutical ingredient.
  90. Lickrish, David; Zhang, Feng, Methods and compositions for treatment of attention deficit disorder.
  91. Goddard, III, William A.; Menna, Mark; Pandol, Stephen; Abrol, Ravinder, Methods and systems for modulating hormones and related methods, agents and compositions.
  92. McKinney, Anthony A.; Tollefson, Gary; Weber, Eckard; Soltero, Rick, Methods for administering weight loss medications.
  93. McKinney, Anthony; Tollefson, Gary; Weber, Eckard; Soltero, Rick, Methods for administering weight loss medications.
  94. Lickrish, David; Zhang, Feng, Methods for treatment of attention deficit hyperactivity disorder.
  95. Lickrish, David; Zhang, Feng, Methods for treatment of attention deficit hyperactivity disorder.
  96. Lickrish, David; Zhang, Feng, Methods for treatment of attention deficit hyperactivity disorder.
  97. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of manufacturing oral dosage forms.
  98. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of manufacturing oral formulations.
  99. Park, Jae Han; Eisenhauer, Tiffani; Dhanarajan, Anish; Gupta, Vishal K.; Overholt, Stephen, Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans.
  100. Park, Jae Han; Eisenhauer, Tiffani; Dhanarajan, Anish; Gupta, Vishal K.; Overholt, Stephen, Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans.
  101. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of providing analgesia.
  102. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of providing analgesia.
  103. Dunayevich, Eduardo; Tollefson, Gary, Methods of providing weight loss therapy in patients with major depression.
  104. Klassen, Preston; Taylor, Kristin, Methods of treating overweight and obesity.
  105. Lickrish, David; Zhang, Feng, Methods of treatment of attention deficit hyperactivity disorder.
  106. Oberegger, Werner; Eradiri, Okponanabofa; Zhou, Fang; Maes, Paul, Modified release tablet of bupropion hydrochloride.
  107. Appel, Leah E.; Ray, Roderick J.; Lyon, David K.; West, James B.; McCray, Scott B.; Crew, Marshall D.; Friesen, Dwayne T.; Herbig, Scott M.; Lo, Julian B., Multiparticulate crystalline drug compositions having controlled release profiles.
  108. Dixit, Manesh; Chen, Chih-Ming; Cheng, Xiu Xiu; Xie, Jianbo, Oral controlled release dosage form.
  109. Dixit, Manesh; Chen, Chih-Ming; Cheng, Xiu Xiu; Xie, Jianbo, Oral controlled release dosage form.
  110. Dixit, Manesh; Chen, Chih-Ming; Cheng, Xiu-Xiu; Xie, Jianbo, Oral controlled release dosage form.
  111. Mistry, Kishor Kumar; Preston, Janine Andrea; Symes, Kenneth Charles, Particles.
  112. Smith, Alan; Dyer, Ann Margaret, Pharmaceutical compositions.
  113. Devarakonda, Krishna; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia.
  114. Devarakonda, Krishna; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia.
  115. Skrtic, Stanko; Johnsson, Jörgen; Lennernäs, Hans; Hedner, Thomas; Johannsson, Gudmundur, Pharmaceutical compositions for glucocorticoid replacement therapy.
  116. Hall, Warren; Olmstead, Kay; Weston, Laura, Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them.
  117. Olmstead, Kay; Hall, Warren; Proehl, Gerald T., Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them.
  118. Olmstead, Kay; Hall, Warren; Proehl, Gerald T., Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them.
  119. Partridge, John J.; Colucci, John; Gareau, Yves; Therien, Michel; Zamboni, Robert; Hafkin, Barry; Marfat, Anthony; Zaghdane, Helmi, Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide.
  120. Partridge, John J.; Colucci, John; Gareau, Yves; Therien, Michel; Zamboni, Robert; Hafkin, Barry; Marfat, Anthony; Zaghdane, Helmi, Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide.
  121. Pauls, Henry; Ramnauth, Jailall, Salts, prodrugs and polymorphs of fab I inhibitors.
  122. Pauls, Henry; Ramnauth, Jailall, Salts, prodrugs and polymorphs of fab I inhibitors.
  123. Zerbe, Horst; Paiement, Nadine; Angusti, Angela; Long, Cormac, Solid oral film dosage forms and methods for making same.
  124. Woo, Jong Soo; Kim, Young Hun, Sustained release composition for oral administration of niacin.
  125. McKinney, Anthony A.; Tollefson, Gary D.; Soltero, Richard; Dunzo, Thea Elise, Sustained release formulation of naltrexone.
  126. McKinney, Anthony A.; Tollefson, Gary D.; Soltero, Richard; Dunzo, Thea Elise, Sustained release formulation of naltrexone.
  127. Saltel, Douglas A.; Vachon, Michael, Sustained release formulations of lorazepam.
  128. Zerbe, Horst G.; Paiement, Nadine, Sustained-release bupropion and bupropion/mecamylamine tablets.
  129. Devarakonda, Krishna; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia.
  130. Devarakonda, Krishna; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia.
  131. Sargent, Bruce J.; Pauls, Henry; Berman, Judd M.; Ramnauth, Jailall; Sampson, Peter; Toro, Andras; Martin, Fernando J.; Surman, Matthew D.; Decornez, Helene Y.; Manning, David D., Therapeutic agents, and methods of making and using the same.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로